Bank of Montreal
XENE icon

Bank of Montreal’s Xenon Pharmaceuticals XENE Stock Holding History

Bank of Montreal’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-909
Closed -$39.3K – 4290
2024
Q1 		$39.3K Buy
+909
New +$41.8K ﹤0.01% 3494
2023
Q3 		– Sell
-191,011
Closed -$7.83M – 4280
2023
Q2 		$7.83M Buy
+191,011
New +$7.59M ﹤0.01% 1127
2021
Q4 		– Sell
-82,967
Closed -$1.25M – 3925
2021
Q3 		$1.25M Sell
82,967
-4,189
-5% -$72.8K ﹤0.01% 2356
2021
Q2 		$1.62M Buy
87,156
+24,588
+39% +$453K ﹤0.01% 2183
2021
Q1 		$1.09M Sell
62,568
-20,219
-24% -$343K ﹤0.01% 2123
2020
Q4 		$1.24M Buy
82,787
+77,787
+1,556% +$910K ﹤0.01% 2097
2020
Q3 		$59K Hold
5,000
– – ﹤0.01% 3355
2020
Q2 		$67K Hold
5,000
– – ﹤0.01% 3280
2020
Q1 		$55K Hold
5,000
– – ﹤0.01% 2858
2019
Q4 		$66K Sell
5,000
-1,198
-19% -$12.6K ﹤0.01% 3707
2019
Q3 		$56K Sell
6,198
-4,523
-42% -$42.8K ﹤0.01% 3560
2019
Q2 		$106K Hold
10,721
– – ﹤0.01% 3299
2019
Q1 		$109K Sell
10,721
-1,000
-9% -$8.48K ﹤0.01% 3019
2018
Q4 		$74K Hold
11,721
– – ﹤0.01% 3104
2018
Q3 		$155K Buy
11,721
+9,523
+433% +$110K ﹤0.01% 2897
2018
Q2 		$20K Sell
2,198
-1,082
-33% -$6.72K ﹤0.01% 3747
2018
Q1 		$16K Buy
+3,280
New +$12.1K ﹤0.01% 3634
2017
Q4 		– Sell
-3,280
Closed -$10K – 4348
2017
Q3 		$10K Sell
3,280
-2,250
-41% -$6.96K ﹤0.01% 3709
2017
Q2 		$17K Sell
5,530
-1,607
-23% -$6.28K ﹤0.01% 3593
2017
Q1 		$29K Hold
7,137
– – ﹤0.01% 3260
2016
Q4 		$56K Hold
7,137
– – ﹤0.01% 3074
2016
Q3 		$58K Hold
7,137
– – ﹤0.01% 3005
2016
Q2 		$42K Hold
7,137
– – ﹤0.01% 3118
2016
Q1 		$50K Hold
7,137
– – ﹤0.01% 3047
2015
Q4 		$57K Sell
7,137
-900
-11% -$7.71K ﹤0.01% 2994
2015
Q3 		$66K Sell
8,037
-1,000
-11% -$9.93K ﹤0.01% 2814
2015
Q2 		$105K Buy
+9,037
New +$125K ﹤0.01% 2729

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of Montreal's XENE Position: Q2 2024 in Review

Bank of Montreal sold out of Xenon Pharmaceuticals (XENE) in Q2 2024, closing a stake of 909 shares — an estimated $39.3K sold.

Bank of Montreal first reported a position in XENE in Q2 2015 and held it in 27 quarters. The position peaked at $7.83M in Q2 2023. 213 funds tracked by Wall St. Rank hold XENE as of Q2 2024.

  • Bank of Montreal reported no remaining Xenon Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Bank of Montreal sold 909 Xenon Pharmaceuticals shares in Q2 2024, an estimated $39.3K.
  • Bank of Montreal first reported a position in Xenon Pharmaceuticals in Q2 2015 and held it in 27 quarters.
  • Bank of Montreal's Xenon Pharmaceuticals position peaked at $7.83M in Q2 2023.
  • 213 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2024.

Based on Bank of Montreal's 13F filing for Q2 2024, filed 14 Aug 2024.